The high burden of cervical cancer in Fiji, 2004-07

Sexual Health

Volumn 10, Issue 2, 2013, Pages 171-178

  Law, Irwin ^a,b   Fong, James J ^c   Buadromo, Eka M ^c   Samuela, Josaia ^c   Patel, Mahomed S ^a   Garland, Suzanne M ^b,d   Mulholland, E Kim ^e,f   Russell, Fiona M ^b  

^a The Australian National University   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Ministry of Health   (Fiji)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

epidemiology; human papillomavirus; Pap smear; South Pacific

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CAUSE OF DEATH; ETHNICITY; FEMALE; FIJI; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; FEMALE; FIJI; HUMANS; INCIDENCE; MIDDLE AGED; REGISTRIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84876580717     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH12135     Document Type: Article

References (44)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(12): 2893-917. doi:10.1002/ijc.25516
2. Foliaki S, Jeffreys M, Wright C, Blakey K, Pearce N. Cancer in Pacific people in New Zealand: a descriptive study. Pac Health Dialog 2004; 11(2): 94-100.
3. McCracken M, Olsen M, Chen MS, Jemal A, Thun M, Cokkinides V, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 2007; 57(4): 190-205. doi:10.3322/canjclin.57.4.190 (Pubitemid 47312080)
4. Sankaranarayanan R. Overview of cervical cancer in the developing world. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006; 95: S205-10. doi:10.1016/S0020-7292(06)60035-0 (Pubitemid 44856728)
5. Canfell K, Sitas F, Beral V. Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Med J Aust 2006; 185(9): 482-6. (Pubitemid 44767075)
6. Nygard JF, Skare GB, Thoresen SO. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. J Med Screen 2002; 9(2): 86-91. doi:10.1136/jms.9.2.86 (Pubitemid 34822870)
7. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Health Organ 2001; 79(10): 954-62. (Pubitemid 33027175)
8. World Health Organization. Control of cancer of the cervix uteri: review article based on a report of a WHO meeting, November 1985. Bull World Health Organ 1986; 64: 607-18.
9. Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 2008; 5(6): e132. doi:10.1371/journal.pmed.0050132 (Pubitemid 351919106)
10. Muwonge R, da Ganda Manuel M, Filipe AP, Dumas JB, Frank MR, Sankaranarayanan R. Visual screening for early detection of cervical neoplasia in Angola. Int J Gynaecol Obstet 2010; 111(1): 68-72. doi:10.1016/j.ijgo.2010. 04.024
11. Nessa A, Hussain MA, Rahman JN, Rashid MH, Muwonge R, Sankaranarayanan R. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid. Int J Gynaecol Obstet 2010; 111(2): 115-8. doi:10.1016/j.ijgo.2010. 06.004
12. Ngoma T, Muwonge R, Mwaiselage J, Kawegere J, Bukori P, Sankaranarayanan R. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int J Gynaecol Obstet 2010; 109(2): 100-4. doi:10.1016/j.ijgo.2009.11. 025
13. Palanuwong B. Alternative cervical cancer prevention in lowresource settings: experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand. Aust N Z J Obstet Gynaecol 2007; 47(1): 54-60. doi:10.1111/j.1479-828X.2006. 00680.x (Pubitemid 46152472)
14. Zhao FH, Lin MJ, Chen F, Hu SY, Zhang R, Belinson JL, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol 2010; 11(12): 1160-71. doi:10.1016/S1470- 2045(10)70256-4
15. Foliaki S, Best D, 'Akau'ola S, Cheng S, Borman B, Pearce N. Cancer incidence in four Pacific countries: Tonga, Fiji Islands, Cook Islands and Niue. Pac Health Dialog 2011; 17(1): 21-32.
16. Ault KA. Effect of prophylactic human papillomavirus L1 virus-likeparticle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007; 369(9576): 1861-8. doi:10.1016/S0140-6736(07) 60852-6 (Pubitemid 46829356)
17. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a doubleblind, randomised study in young women. Lancet 2009; 374(9686): 301-14. doi:10.1016/S0140-6736(09)61248-4
18. Sampson Handley W. The prevention of cancer. Lancet 1936; 227 (5879): 987-91. doi:10.1016/S0140-6736(01)37110-6
19. Lyster WR. Uterine cancer in the circumcised and uncircumcised populations of Fiji. Med J Aust 1967; 2(22): 993.
20. Lancaster DJ. Racial incidence of carcinoma of the cervix in Fiji. Aust N Z J Obstet Gynaecol 1972; 12(4): 228-30. doi:10.1111/j.1479-828X.1972.tb00510.x
21. Boyd JT, Doll R, Gurd CH. Cancer incidence in Fiji. Int J Epidemiol 1973; 2(2): 177-87. doi:10.1093/ije/2.2.177
22. Paksoy N, Montaville B, McCarthy SW. Cancer occurrence in Vanuatu in the South Pacific, 1980-86. Asia Pac J Public Health 1989; 3(3): 231-6. doi:10.1177/101053958900300310
23. Paksoy N, Bouchardy C, Parkin DM. Cancer incidence in Western Samoa. Int J Epidemiol 1991; 20(3): 634-41. doi:10.1093/ije/20.3.634
24. Fiji Islands Bureau of Statistics (FIBS). Census of population and housing (2007). Suva: FIBS; 2009. Available online at: http://www. statsfiji.gov.fj/Census2007/census07-index2.htm [verified August 2012].
25. World Health Organization (WHO). Global health observatory. Geneva: WHO; 2012. Available online at: http://apps.who.int/gho/data/[verified August 2012].
26. Ahmad O, Boschi-Pinto C, Lopez A, Murray C, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Report no. 31. Geneva: World Health Organization; 2000. Available online at: http://www.who.int/healthinfo/ paper31.pdf [verified August 2012].
27. Australian Institute of Health and Welfare (AIHW). Cervical screening in Australia 2007-2008: data report. Cancer series no. 54. Cat. no. CAN 50. Canberra: AIHW; 2010. Available online at: http://www.aihw.gov.au/publication- detail/?id=6442468364 [verified August 2012].
28. Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, et al. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention. Vaccine 2008; 26: M80-8. doi:10.1016/j.vaccine.2008.05.041
29. Ministry of Health. Cancer: new registrations and deaths 2007: revised edition. Wellington: Ministry of Health; 2010. Available online at: http://www.health.govt.nz/publication/cancer-new-registrations-anddeaths-2007 [verified August 2012].
30. Ferlay JSH, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, cancer incidence and mortality worldwide. IARC CancerBase No. 10. Lyon: International Agency for Research on Cancer; 2010. Available online at: http://globocan.iarc. fr [verified August 2012].
31. Gyaneshwar R, Nsanze H, Singh KP, Pillay S, Seruvatu I. The prevalence of sexually transmitted disease agents in pregnant women in Suva. Aust N Z J Obstet Gynaecol 1987; 27(3): 213-5. doi:10.1111/j.1479-828X.1987.tb00989.x
32. Fiji Islands Bureau of Statistics (FIBS). Poverty indicators. Suva: FIBS; 2007. Available online at: http://www.statsfiji.gov.fj/Social/poverty- indicators.htm [verified August 2012].
33. Prasad K, Fong J. The effectiveness of cervical cancer screening programme at Colonial War Memorial Hospital. Fiji Med J 2007; 26: 9-12.
34. World Health Organization (WHO). Comprehensive cervical cancer control: a guide to essential practice. Geneva: WHO; 2006. Available online at: http://www.who.int/reproductivehealth/publications/cancers/9241547006/en/index. html [verified August 2012].
35. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008; 26(Suppl 10): K29-41. doi:10.1016/j.vaccine.2008.06.019
36. Sherris J, Wittet S, Kleine A, Sellors J, Luciani S, Sankaranarayanan R, et al. Evidence-based, alternative cervical cancer screening approaches in low-resource settings. Int Perspect Sex Reprod Health 2009; 35(3): 147-54. doi:10.1363/3514709
37. Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC. Screen-and-treat approaches for cervical cancer prevention in lowresource settings: a randomized controlled trial. JAMA 2005; 294(17): 2173-81. doi:10.1001/jama.294.17.2173 (Pubitemid 41571134)
38. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008; 9(10): 929-36. doi:10.1016/S1470-2045(08) 70210-9
39. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360(14): 1385-94. doi:10.1056/NEJMoa0808516
40. World Health Organization (WHO). Human papillomavirus vaccines WHO position paper. Weekly Epidemiological Record World Health Organization 2009; 84(15): 118-31.
41. Tabrizi SN, Law I, Buadromo E, Stevens MP, Fong J, Samuela J, et al. Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Fiji. Sex Health 2011; 8(3): 338-42. doi:10.1071/SH10083
42. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377(9783): 2085-92. doi:10.1016/S0140-6736(11)60551-5
43. Cuzick J, Castanon A, Sasieni P. Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. Br J Cancer 2010; 102 (5): 933-9. doi:10.1038/sj.bjc.6605528
44. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011; 11(1): 39-44. doi:10.1016/S1473-3099(10) 70225-5